Compare TDF & EMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TDF | EMBC |
|---|---|---|
| Founded | 1994 | 1924 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 268.9M | 279.9M |
| IPO Year | N/A | 2021 |
| Metric | TDF | EMBC |
|---|---|---|
| Price | $10.21 | $5.25 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $18.50 |
| AVG Volume (30 Days) | 39.3K | ★ 1.2M |
| Earning Date | 01-01-0001 | 05-05-2026 |
| Dividend Yield | N/A | ★ 6.88% |
| EPS Growth | N/A | ★ 20.90 |
| EPS | N/A | ★ 1.03 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $1.17 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $4.94 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $10.26 | $2.77 |
| 52 Week High | $12.20 | $15.55 |
| Indicator | TDF | EMBC |
|---|---|---|
| Relative Strength Index (RSI) | 30.55 | 52.77 |
| Support Level | N/A | $4.80 |
| Resistance Level | $11.14 | $5.77 |
| Average True Range (ATR) | 0.19 | 0.27 |
| MACD | -0.05 | -0.09 |
| Stochastic Oscillator | 7.79 | 26.13 |
Templeton Dragon Fund Inc is a closed-end management investment company. The fund seeks long-term capital appreciation by investing majority of its total assets in equity securities of China companies. It invest in various sectors such as gas & consumable fuels, auto components, banks, beverages, communications equipment, healthcare equipment & supplies, restaurants & leisure, household durables and many others.
Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.